The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tlapshokova L.B.

Berbekov Kabardino-Balkar State University

Zikhova A.R.

Berbekov Kabardino-Balkar State University

Risk factors for multiple sclerosis in the Kabardino-Balkar Republic

Authors:

Tlapshokova L.B., Zikhova A.R.

More about the authors

Read: 1512 times


To cite this article:

Tlapshokova LB, Zikhova AR. Risk factors for multiple sclerosis in the Kabardino-Balkar Republic. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7‑2):65‑69. (In Russ.)
https://doi.org/10.17116/jnevro202112107265

Recommended articles:
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124
Epidemiology and prevention of prostate cancer. Russian Journal of Preventive Medi­cine. 2025;(7):111-118

References:

  1. Boyko AN, Gusev EI. Modern algorithms for the diagnosis and treatment of multiple sclerosis, based on an individual assessment of the patient’s condition. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;2(2):92-106. (In Russ.). https://doi.org/10.17116/jnevro20171172292-106
  2. Kozhieva M, Naumova N, Alikina N, et al. The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis. Life (Basel). 2021;11(1):55.  https://doi.org/10.3390/life11010055
  3. Losonczi E, Bencsik K, Fricska Nagy Z, et al. APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis. Swiss Medical Weekly. 2010;140:13119. https://doi.org/10.4414/smw.2010.13119
  4. Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134-142.  https://doi.org/10.1016/j.jaut.2014.01.022
  5. Höftberger R, Guo Y, Flanagan E, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020;139(5):875-892.  https://doi.org/10.1007/s00401-020-02132-y
  6. Sawcer S, Franklin R, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13:700-718.  https://doi.org/10.1016/S1474-4422(14)70041-9
  7. Losonczi E, Bencsik K, Fricska Nagy Z, et al. APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis. Swiss Medical Weekly. 2010;140:13119. https://doi.org/10.4414/smw.2010.13119
  8. Popova EV, Kiselev IS, Boyko AN, et al. Polymorphic variants of the immune response genes as risk factors for primary progressive multiple sclerosis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;2(2):14-21. (In Russ.). https://doi.org/10.17116/jnevro20171172214-21
  9. Nada MA, Labib DA. Tumor necrosis factor alpha gene -376 polymorphism and susceptibility to multiple sclerosis: an Egyptian study. Journal of Neuroimmune Pharmacology. 2011;6(1):142-147. 
  10. Rosjo E, Myhr K, Loken-Amsrud KI, Bakke S, et al. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. J Neuroimmunol. 2015;280:21-28. 
  11. Sundqvist E, Bergström T, Daialhosein H, et al. Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler. 2014;20:165-171. 
  12. Mielcarz D, Kasper L. The gut microbiome in multiple sclerosis. Curr Treat Options Neurol. 2015;17:344-350. 
  13. Ramanujam R, Hedström A, Manouchehrinia A, et al. Effect of Smoking Cessation on Multiple Sclerosis Prognosis. JAMA Neurol. 2015;72:1117-1123.
  14. Rivera V. Multiple Sclerosis in Latin Americans: Genetic Aspects. Curr Neurol Neurosci Rep. 2017;17(8):57-63. 
  15. Bakhtiyarova KZ, Goncharova ZA. Multiple sclerosis in the Republic of Bashkortostan and the Rostov region: comparative epidemiological characteristics. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(2):5-9. (In Russ.).
  16. Boyko AN, Kukel TM, Lysenko MA, et al. Clinical epidemiology of multiple sclerosis in Moscow. Modern clinical and demographic features on the example of the population of one of the districts of the city. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(2):10-15. (In Russ.).
  17. Magomedov MM, Khalitov IA, Mikhailova BI. Multiple sclerosis in Dagestan. Basic research. 2009;9:51-52. (In Russ.).
  18. Khodova MA, Sivertseva SA, Smirnova NF, et al. Ecological characteristics of the place of residence and the risk of multiple sclerosis in the Republic of North Ossetia-Alania. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;10(2):6-12. (In Russ.).
  19. Boiko A. Guidelines for questionnaires to be used in case-control studies of MS. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 1997;49:2(2):75-80. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.